honokiol has been researched along with Breast Neoplasms in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 16 (53.33) | 24.3611 |
| 2020's | 9 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, D; Guan, S; Li, D; Liu, D; Wang, J; Xing, G; Yue, L; Zhang, Q | 1 |
| Lu, X; Lv, H; Yang, P; Zhang, Z | 1 |
| Cai, D; Guan, S; Li, D; Li, H; Li, X; Liu, D; Wang, J; Xing, G; Yue, L; Zhang, Q; Zhu, W | 1 |
| Abbasi, SW; Akbar, A; Jahangir, M; Mehnaz, S; Raza, RZ; Riasat, A; Shahid, I; Shoaib, M | 1 |
| Hardisty, S; Kerr, K; McAlister, K; McCullough, I; Thulasiraman, P; Wistner, A | 1 |
| He, K; Jiang, M; Li, J; Liu, Q; Qiu, T; Sun, J; Yang, M; Zhan, S; Zhang, X | 1 |
| Hafiz, AA; Haggag, YA; Ibrahim, RR | 1 |
| Cai, D; Fan, L; Guan, S; Liu, D; Wang, J; Zhang, Q; Zhu, W | 1 |
| Lou, L; Wang, J; Xiong, J; Yi, X; Zhou, S | 1 |
| Chen, Y; Hu, X; Li, J; Li, Y; Qu, J; Wang, D; Wang, Z; Xia, M; Yuan, R; Zhang, H; Zhang, Y | 1 |
| Afthinos, A; Arbiser, JL; Begum, A; Bonner, MY; Cho, S; Győrffy, B; Huang, CY; Konstantopoulos, K; Korangath, P; Kuppusamy, P; Lanoue, D; Marignani, PA; Matsui, W; Merino, VF; Mistriotis, P; Muniraj, N; Nagalingam, A; Saxena, NK; Sengupta, S; Sharma, D; Shriver, M; Sukumar, S | 1 |
| Deng, Y; He, C; Jin, Y; Li, X; Liu, Y; Qu, X; Wang, D; Wang, Z; Zhou, Y; Zou, Y | 1 |
| Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Qiu, X; Song, XL; Wang, T | 1 |
| Guo, Y; Han, M; Liu, B; Wang, X; Yu, R; Zou, Y | 1 |
| Chen, SZ; Li, Y; Shang, Y; Wang, WD | 1 |
| Arbiser, JL; Avtanski, DB; Bonner, MY; Nagalingam, A; Saxena, NK; Sharma, D | 2 |
| Arbiser, JL; Avtanski, DB; Bonner, MY; Kuppusamy, P; Nagalingam, A; Saxena, NK; Sharma, D | 1 |
| Alitongbieke, G; Cai, L; Chen, QC; Jiang, F; Liu, J; Meng, M; Ren, A; Shi, X; Su, Y; Wang, G; Wang, J; Xie, L; Xu, Y; Zeng, Z; Zhang, X; Zhang, XK; Zhou, H; Zhou, Y | 1 |
| Johnson, AB; Thulasiraman, P | 1 |
| Gong, C; He, T; Nie, S; Song, L; Wang, N; Wang, Z; Wu, Q; Yang, S; Yang, X; Yi, C | 1 |
| Chen, L; Chen, X; Hou, W; Hu, J; Jiang, Q; Tang, M; Wang, X; Wei, Y; Wen, J; Yang, G; Yuan, Y; Zhong, Z; Zhou, H | 1 |
| Elstner, E; Emde, A; Eucker, J; Kühnl, A; Liu, H; Planas-Silva, MD; Possinger, K; Rosche, M; Schulz, CO; Zang, C | 1 |
| Bae, K; Chung, HJ; Hong, JY; Hung, TM; Kang, SS; Kang, YJ; Kim, YS; Lee, SK; Min, HY; Park, EJ; Youn, UJ | 1 |
| Katiyar, SK; Singh, T | 1 |
| Arbiser, JL; Bonner, MY; Nagalingam, A; Saxena, NK; Sharma, D | 1 |
| Deng, Y; He, H; Li, L; Sun, J; Tian, W; Xu, D | 1 |
| Chen, Q; Hou, X; Wang, S; Yuan, X; Zhang, B | 1 |
| Hu, X; Lu, Q; Xu, D | 1 |
| Amblard, F; Arbiser, JL; Karlan, BY; Koeffler, HP; Nguyen, A; O'Kelly, J; Wakimoto, N; Wolf, I | 1 |
30 other study(ies) available for honokiol and Breast Neoplasms
| Article | Year |
|---|---|
Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis.
Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Drug Carriers; Female; Humans; Lignans; Mice; Nanoparticles; Particle Size; Sialic Acids; Tissue Distribution; Zein | 2022 |
Honokiol nanosuspensions loaded thermosensitive hydrogels as the local delivery system in combination with systemic paclitaxel for synergistic therapy of breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Hydrogels; Lignans; Mice; Nanoparticles; Paclitaxel | 2022 |
Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Humans; Liposomes; Mice | 2023 |
Topics: Biphenyl Compounds; Breast Neoplasms; Female; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Serine-Threonine Kinases | 2023 |
Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells.
Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Proliferation; Female; Humans; Lignans; N-Acetylneuraminic Acid; Neuraminidase | 2019 |
Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Celecoxib; Lignans; Mice; Mice, Inbred BALB C; Polyesters; Polyethylene Glycols; Vitamin E | 2020 |
Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Drug Delivery Systems; Female; Humans; Lignans; MCF-7 Cells; Mice; Micelles; Nanocapsules; Polyethylene Glycols; Polyglactin 910; Solubility; Xenograft Model Antitumor Assays | 2020 |
Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Movement; Cell Proliferation; Drug Carriers; Drug Screening Assays, Antitumor; Female; Hyaluronic Acid; Lignans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Tumor Cells, Cultured; Zein | 2020 |
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; F-Box-WD Repeat-Containing Protein 7; Female; Gene Expression Regulation, Neoplastic; Humans; Lignans; MicroRNAs; Proto-Oncogene Proteins c-myc; Signal Transduction | 2021 |
Augment the efficacy of eradicating metastatic lesions and tumor proliferation in breast cancer by honokiol-loaded pH-sensitive targeted lipid nanoparticles.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrogen-Ion Concentration; Lignans; Lipids; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles | 2021 |
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Female; Humans; Lignans; Mice; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Breast Neoplasms; Drug Delivery Systems; Female; Humans; Lignans; MCF-7 Cells; Neoplasm Metastasis; Paclitaxel | 2017 |
Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels.
Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cations; Daunorubicin; Female; Humans; Hyaluronic Acid; Lignans; Liposomes; MCF-7 Cells; Mice; Neovascularization, Pathologic | 2018 |
Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Proliferation; Drug Carriers; Drug Screening Assays, Antitumor; Female; Folic Acid; Hydrogen-Ion Concentration; Indoles; Lignans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Optical Imaging; Particle Size; Polymers; Surface Properties | 2019 |
Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; Lignans; Lung Neoplasms; Mice, Inbred BALB C; Snail Family Transcription Factors | 2019 |
Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast; Breast Neoplasms; Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Homeodomain Proteins; Humans; Lignans; Magnolia; Signal Transduction; STAT3 Transcription Factor; Transcription Factors; Zinc Finger E-box-Binding Homeobox 1 | 2014 |
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Topics: Animals; Antineoplastic Agents, Phytogenic; beta Catenin; Biphenyl Compounds; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Drugs, Chinese Herbal; Female; Histone Deacetylases; Humans; Leptin; Lignans; Magnolia; MCF-7 Cells; Mice; Mice, Nude; Mice, Obese; MicroRNAs; Neoplasm Invasiveness; Obesity; Phosphorylation; Plant Extracts; Promoter Regions, Genetic; Repressor Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Wnt1 Protein; Xenograft Model Antitumor Assays | 2015 |
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Leptin; Lignans; MCF-7 Cells; Mice; MicroRNAs; Microscopy, Confocal; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2015 |
Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression.
Topics: Animals; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Hep G2 Cells; Humans; Lignans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Receptor Subfamily 4, Group A, Member 1; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2016 |
Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Breast Neoplasms; Down-Regulation; Doxorubicin; Drug Synergism; Female; Gene Expression; Humans; Lignans; MCF-7 Cells; Mucin-1; Multidrug Resistance-Associated Proteins; RNA, Small Interfering; Transfection | 2016 |
Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biocompatible Materials; Biphenyl Compounds; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Liberation; Endocytosis; Female; HEK293 Cells; Humans; Immunohistochemistry; Lignans; Mice, Inbred BALB C; Micelles; Paclitaxel; Particle Size; Polymers | 2017 |
Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Female; Lignans; Liposomes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Xenograft Model Antitumor Assays | 2008 |
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Lignans; Magnolia; Medicine, Chinese Traditional; Quinazolines; Signal Transduction; Sirolimus; Time Factors | 2008 |
Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Down-Regulation; ErbB Receptors; Female; Humans; Lignans; Phosphorylation; Protein-Tyrosine Kinases; Signal Transduction; src-Family Kinases; Tumor Suppressor Proteins | 2009 |
Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Humans; Lignans; Magnolia; Mice; Models, Biological; Molecular Targeted Therapy; Nitric Oxide; Phytotherapy | 2011 |
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Enzyme Activation; Female; Gene Expression; Humans; Lignans; Mice; Mice, Nude; Neoplasm Invasiveness; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Spheroids, Cellular; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death.
Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cyclophilins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Lignans; MCF-7 Cells; Peptidyl-Prolyl Isomerase F | 2013 |
Screening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Female; Humans; Lignans; Magnolia; Mass Spectrometry | 2013 |
Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Drugs, Chinese Herbal; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Lignans; Magnolia; Rhodamine 123; RNA, Messenger; Time Factors | 2006 |
Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Doxorubicin; Drug Synergism; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Lignans; Mice; Mice, Nude; Paclitaxel; Tamoxifen; Vorinostat | 2007 |